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Introduction
PFAPA (Periodic Fever with Aphtous stomatitis, Pharyngi-
tis and cervical Adenitis) is a periodic syndrome described
for the first time in 1987 by Marshal et al. In 1999 the
diagnostic criteria were formulated by Thomas.
Objectives
All the patients who received a PFAPA diagnosis at our
Centre between 1999 and 2012 were prospectively
evaluated.
Methods
Sex, age at onset, age at diagnosis, family history, clinical
characteristic of the febrile episodes and associated symp-
toms, prodromes, therapy, therapy response and age at
resolution were collected.
Results
In our cohort (148 males and 120 females) fever began
at 26.2 + 24 months of age. 8% of the patients had an
onset after the fifth year of life, but all other Thomas
criteria were met. A family history was present in 39.6%
of patients. Mean duration of PFAPA episodes was 4 +
1.6 days, and a mean interval between episodes 27.9 + 11
days. Most common symptoms with fever were pharyngi-
tis (95.5%), cervical adenitis (63.8%), stomatous aphtosis
(38.4%), abdominal pain (32%). Prodromes, such as irrit-
ability, nausea and headache were present in 10% of
patients. All patients received treatment with oral steroids,
using a single administration of 1 mg/kg of prednisone or
prednisone equivalent, the first day of fever. In all patients
steroids were effective and only 13 % of them experienced
a free-interval shortening, without the perceived need to
stop the steroids for this reason. There was no difference
in the studied parameters between the population who
experienced a free-interval shortening and the population
in which this event was not registered.
In 144 children resolution occurred, in 58 % of children
spontaneously and in 42 % after tonsillectomy. Mean
disease duration was 40 + 63 months, medium age at reso-
lution 67.7 + 66 months. Tonsillectomy was efficacious in
60/62 patients. Mutation analysis for FMF, HIDS, and
TRAPS in the latter two patients were negative. The ton-
sillectomy was done after a mean period of 36 months
from disease onset.
At multivariate regression analysis disease resolution
was independently associated to age onset (b = 1.011 95 %
CI 1.000-1.022, p = 0.05) and to tonsillectomy (b = 0.022
95 %CI 0.005-0.092 p = 0.001).
Conclusion
PFAPA is the most common cause of periodic fever in
children, however our study confirms that the 5 year of
age at disease onset criterion is too strict. Symptoms
other than the ones from the classic description, such as
abdominal pain, could have clinical relevance. Prodromes
are quite common and useful in differentiate the typical
PFAPA attack from other episodes of fever. Oral steroids
are, in our opinion, the therapy of choice and the free-
interval shortening is not perceived as a clinically relevant
issue. It is not possible to predict which patients would
present this effect. Tonsillectomy is very effective, but
should be reserved to a very selected group of patients
and with ad adequate period of follow-up before the sur-
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